Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.caplinpoint.net | |
Market Cap | 9,197.18 Cr. | |
Enterprise Value(EV) | 8,605.46 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 55.03 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 22.01 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.54 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 273.06 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 4.44 | Calculated using Price: 1,211.10 |
Dividend Yield | 0.37 | Period Ending 2023-03 |
No. of Shares Subscribed | 7.59 Cr. | 75,940,746 Shares |
FaceValue | 2 | |
About Caplin Point Laboratories Ltd. | ||
Caplin Point is the mid-sized company in India's pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility. |
1 Day |
|
-1.67% |
1 Week |
|
-3.67% |
1 Month |
|
+12.21% |
3 Month |
|
+12.67% |
6 Month |
|
+55.29% |
1 Year |
|
+62.90% |
2 Year |
|
+54.63% |
5 Year |
|
+204.60% |
10 Year |
|
+7664.95% |
9 years | 2015-06 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 55.78 | 43.13 | 54.97 | 49.43 | 37.14 | 29.58 | 25.65 | 24.77 | 23.68 | |
Return on Capital Employed (%) | 71.11 | 55.41 | 69.03 | 64.08 | 45.59 | 33.35 | 28.82 | 28.77 | 26.85 | |
Return on Assets (%) | 20.12 | 18.46 | 30.54 | 33.68 | 28.41 | 23.02 | 20.20 | 19.94 | 19.29 |
Particulars | 10 years | 2015-06 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 93 | 128 | 225 | 364 | 633 | 948 | 1,186 | 1,484 | 1,880 | 2,074 | |
Non Curr. Liab. | 10 | 14 | 20 | 28 | 23 | 25 | 17 | 13 | 2 | 0 | |
Curr. Liab. | 125 | 125 | 113 | 109 | 86 | 144 | 143 | 208 | 268 | 294 | |
Minority Int. | 0 | 0 | 0 | 0 | 0 | 9 | 18 | 26 | 27 | 29 | |
Equity & Liab. | 229 | 267 | 358 | 500 | 743 | 1,126 | 1,364 | 1,730 | 2,178 | 2,397 | |
Non Curr. Assets | 147 | 149 | 179 | 196 | 249 | 303 | 349 | 432 | 623 | 728 | |
Curr. Assets | 82 | 119 | 179 | 304 | 494 | 823 | 1,015 | 1,298 | 1,554 | 1,668 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 229 | 267 | 358 | 500 | 743 | 1,126 | 1,364 | 1,730 | 2,178 | 2,397 |
Particulars | 10 years | 2015-06 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 252 | 239 | 402 | 540 | 649 | 863 | 1,061 | 1,269 | 1,467 | 1,567 | |
Other Income | 3 | 4 | 10 | 13 | 19 | 41 | 28 | 39 | 57 | 58 | |
Total Income | 255 | 242 | 412 | 553 | 668 | 905 | 1,089 | 1,308 | 1,523 | 1,625 | |
Total Expenditure | -192 | -175 | -277 | -345 | -417 | -603 | -737 | -875 | -1,026 | -1,070 | |
PBIDT | 63 | 68 | 135 | 208 | 251 | 301 | 352 | 433 | 497 | 555 | |
Interest | -1 | 0 | -1 | -1 | -1 | 0 | -2 | -1 | -1 | -1 | |
Depreciation | -8 | -7 | -13 | -19 | -23 | -32 | -37 | -47 | -45 | -46 | |
Taxation | -12 | -14 | -25 | -44 | -50 | -54 | -62 | -77 | -74 | -90 | |
Exceptional Items | |||||||||||
PAT | 41 | 46 | 96 | 145 | 177 | 215 | 251 | 308 | 377 | 419 | |
Minority Interest | 0 | 0 | 0 | 0 | -9 | -9 | -1 | -1 | |||
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 41 | 46 | 96 | 145 | 177 | 215 | 242 | 300 | 376 | 418 | |
Adjusted EPS | 5 | 6 | 13 | 19 | 23 | 28 | 32 | 40 | 50 | 55 |
Particulars | 10 years | 2014-06 Rs. Cr. | 2015-06 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 60 | 50 | 42 | 68 | 66 | 83 | 45 | 269 | 337 | 271 | |
Cash Fr. Inv. | -44 | -23 | -6 | -36 | -69 | -100 | -55 | -29 | -377 | -218 | |
Cash Fr. Finan. | -6 | -9 | -14 | -7 | -12 | 90 | 80 | -24 | -41 | -28 | |
Net Change | 10 | 19 | 23 | 25 | -14 | 73 | 70 | 215 | -81 | 26 | |
Cash & Cash Eqvt | 27 | 45 | 68 | 91 | 77 | 151 | 221 | 436 | 151 | 178 |
Fri, 01 Dec 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Details of loss of share certificate is attached herewith |
Fri, 17 Nov 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Earnings Call Transcript is enclosed |
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement w.r.t to Q2 (2023-24) financial results is attached |
Fri, 08 Dec 2023 |
|
|
|
|
|